Neo Performance's Rally Hits a Crossroads: Record Numbers, Falling Shares

Neo Performance Materials beats Q2 estimates but shares slide 9% as investors weigh rare metals price sustainability and cash burn concerns.

The arithmetic looks contradictory at first glance. Neo Performance Materials delivered a second-quarter earnings report that blew past every meaningful estimate, yet the market response was a shrug at best — and a sell-off at worst. The shares slipped roughly 9 percent on Thursday, a day after the company's blowout numbers hit the wire, before settling into a pattern of steady erosion that has left investors parsing whether they're watching a healthy pause or the start of something more uncomfortable.

In German trading, the stock changed hands at €22.86 on Thursday, down 2.0 percent on the day and 8.2 percent below where it stood a week earlier. That puts the shares roughly 25 percent beneath the 52-week high of €30.50, a level reached just days ago. The pullback is all the more striking given the run that preceded it: Neo Performance is still up 136 percent since the start of the year and 120 percent over the past twelve months. A stock that has more than doubled in a year doesn't need much of an excuse to give some of that back.

The quarterly numbers themselves were hardly the problem. Adjusted EBITDA for the second quarter of 2026 came in at $57.0 million — more than triple the $19.0 million posted in the same period a year earlier. Revenue climbed to $205.7 million, comfortably ahead of the $169.1 million analysts had penciled in. The engine behind the surge was the Rare Metals segment, where record prices for hafnium, gallium and tantalum drove a 313 percent jump in adjusted EBITDA contribution, adding $44.4 million to the quarter's total.

So why the cold shoulder? The market's discomfort appears to center on what happens next. Management reaffirmed full-year guidance of adjusted EBITDA between $140 million and $150 million, suggesting the upper end of that range is within reach — a near-doubling of the $76 million generated in 2025. But hitting that target hinges on a single variable: whether rare metals prices hold at their current elevated levels or begin to normalize. With the Rare Metals segment alone accounting for such a large slice of quarterly EBITDA, any softening in those markets would quickly ripple through the full-year picture.

There are other reasons for caution buried in the report. The company burned through $49.6 million in operating cash during the first half of 2026, a figure that reflects higher strategic inventory builds, rising receivables and the final settlement of a European patent dispute that was originally resolved in January. That cash outflow alongside exploding profits raises a legitimate question about how much of the EBITDA growth is converting into actual substance. The stock's annualized 30-day volatility of 83 percent adds another layer of fragility, suggesting the market views the rare metals price spike as something less than permanent.

The bulls, for their part, see the pullback as a gift. The geopolitical backdrop remains firmly in Neo Performance's favor: China still controls the bulk of global rare earth mining and refining, and Western governments are scrambling to build alternative supply chains. The European Union's emergency task force on critical raw materials and initiatives like the Critical Raw Materials Act could provide structural tailwinds for years to come. The company's Estonian expansion in Narva — where samples have been shipped for customer qualification and commercial production for two to three customer programs is slated to begin by the end of 2026 — would cement its position as a European supplier of heavy rare earths like dysprosium and terbium.

The Magnequench segment adds further support. Despite a 6.3 percent decline in overall volumes, deliveries of polymer-bonded magnets rose 35 percent on better pricing. Stifel Nicolaus raised its price target on the stock Wednesday from C$49 to C$55, maintaining a buy rating. ATB Cormark carries an outperform rating with a target of roughly C$53.50, while BMO Capital sits at the top of the range with a C$60 target. All three see meaningful upside from current levels.

Technically, the stock is hovering just above its 50-day moving average of €22.77 — a level that often acts as support and could mark the line between a consolidation and something more serious. If the shares hold that zone and the fundamental story around critical materials remains intact, the current weakness reads as digestion of a spectacular run rather than a structural break. A sustained move below recent lows, however, would flash a warning that the correction has further to go, particularly given how violently the stock can swing in both directions.

The next concrete test arrives with the planned production start in Narva. If the transition to commercial customer programs proceeds on schedule, it would bolster the argument that Neo Performance's growth rests not merely on volatile metal prices but on diversified, long-term customer relationships. Until then, the market's verdict on whether this is a buying opportunity or an exit signal will likely hinge on the daily price action of three obscure metals — and the patience of investors who have already enjoyed a remarkable year.